Skip to Content

U 787 (Glipizide and Metformin 2.5 mg / 250 mg)

Pill imprint U 787 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 250 mg.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glipizide and metformin hydrochloride 2.5 mg / 250 mg U 787  Front
Glipizide and metformin hydrochloride 2.5 mg / 250 mg U 787  Back
Discount Card Promo
Glipizide and metformin hydrochloride
Imprint:
U 787
Strength:
2.5 mg / 250 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
USV Limited
National Drug Code (NDC):
23155-0115
Inactive Ingredients:
sodium starch glycolate type A potato
corn starch
povidone
magnesium stearate
silicon dioxide
hypromellose 2910 (15 mPa.s)
magnesium silicate
titanium dioxide
polyethylene glycol 6000
propylene glycol
ferric oxide red

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide